Strategy Inc - 8.00% Series A Perpetual Strike Preferred Stock (NQ:STRK)
76.04
-0.84
(-1.09%)
Streaming Delayed Price
Updated: 10:05 AM EDT, May 14, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 23,483 |
| Open | 76.30 |
| Bid (Size) | 76.00 (1,000) |
| Ask (Size) | 76.21 (100) |
| Prev. Close | 76.88 |
| Today's Range | 76.01 - 76.90 |
| 52wk Range | 65.12 - 129.48 |
| Shares Outstanding | N/A |
| Dividend Yield | 10.52% |
Top News
More News
Performance
More News
Read More
Strive Adds $50M of STRC to its Corporate Treasury
March 11, 2026
Why Is MSTR Stock Falling In Pre-Market Today? ↗
January 20, 2026
Strategy Joins Open Semantic Interchange
December 02, 2025
Strategy Announces ATM and BTC Activity Updates
October 13, 2025
Frequently Asked Questions
Is Strategy Inc - 8.00% Series A Perpetual Strike Preferred Stock publicly traded?
Yes, Strategy Inc - 8.00% Series A Perpetual Strike Preferred Stock is publicly traded.
What exchange does Strategy Inc - 8.00% Series A Perpetual Strike Preferred Stock trade on?
Strategy Inc - 8.00% Series A Perpetual Strike Preferred Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Strategy Inc - 8.00% Series A Perpetual Strike Preferred Stock?
The ticker symbol for Strategy Inc - 8.00% Series A Perpetual Strike Preferred Stock is STRK on the Nasdaq Stock Market
What is the current price of Strategy Inc - 8.00% Series A Perpetual Strike Preferred Stock?
The current price of Strategy Inc - 8.00% Series A Perpetual Strike Preferred Stock is 76.04
When was Strategy Inc - 8.00% Series A Perpetual Strike Preferred Stock last traded?
The last trade of Strategy Inc - 8.00% Series A Perpetual Strike Preferred Stock was at 05/14/26 10:05 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.